Former Foreign Minister Boris Johnson is seen as the bookmaker's favorite to succeed outgoing Prime Minister Theresa May.Europe Politicsread more
J.P. Morgan economists said they now see a much slower economy in the second quarter, with growth of just 1%.Market Insiderread more
The combination of mounting recession fears, bets on a more cautious Fed and a regular uptick in market volatility could spell more losses, writes Nomura.Marketsread more
An analyst for Ark Invest, which has a major investment in Tesla, says recent drastic price-target cuts by others on Wall Street are missing the big picture.Investingread more
Rep. Chip Roy, R-Texas, has objected to a $19.1 billion disaster relief bill that was expected to pass unanimously Friday. The bill is likely to next be considered when...Politicsread more
If consummated, the deal would mark the latest in a flurry of activity in the payment technology space.Banksread more
The markets have been slow to recognize the high-stakes game that's playing out on the world stage.Economyread more
An altered video of House Speaker Nancy Pelosi made rounds on social media this week, which critics used to attack her mental state.Technologyread more
Stocks were headed for weekly losses on Friday as investors worry the U.S.-China trade war is hurting economic growth.US Marketsread more
One of the biggest Chinese chipmakers is delisting from the New York Stock Exchange amid the trade war, but the company said the decision is not related to the intensifying...Marketsread more
President Donald Trump, his businesses and members of his family on Friday appealed a federal judge's decision that Deutsche Bank and Capital One can turn over years of...Politicsread more
The Food and Drug Administration said Monday it sent warning letters to more than a dozen companies the agency said are "illegally selling" products that claim to prevent or cure Alzheimer's disease.
Many of these products, which are often sold on websites and social media platforms, "have not been reviewed by the FDA and are not proven safe and effective to treat the diseases and health conditions they claim to treat," the FDA said in a press release.
"These products may be ineffective, unsafe and could prevent a person from seeking an appropriate diagnosis and treatment," the agency added.
As many as 5.5 million Americans over the age of 65 suffer from Alzheimer's, a progressive disease that often affects memory, thinking and behavior. The number of Americans with the disease is expected to grow, according to the Department of Health & Human Services.
The FDA is responsible for taking action against any misbranded dietary supplement product after it reaches the market.
More than 50 percent of U.S. adults use dietary supplements, the FDA says. Between 2007 and 2016 nearly 800 over-the-counter dietary supplements were found to contain unapproved drug ingredients, according to a study published in October.
The FDA said the products, which FDA Commissioner Scott Gottlieb labeled a "scam," have come in the form of tablets, capsules and oils. The 17 companies who were sent letters have been asked to respond within 15 days.